BioSpace News Archive

Navigen, Inc. announced that the U.S. Food and Drug Administration has cleared its Investigational New Drug application for the initiation of a Phase I study in healthy volunteers to test the safety, tolerability, and pharmacokinetics of its D-Peptide HIV entry inhibitor, CPT31..

Life sciences industry veteran Marvin Slosman appointed Chief Executive Officer

Daré Bioscience, Inc. announced that it will give one of the feature presentations at the 15th US-Japan Symposium on Drug Delivery Systems taking place Saturday, December 14 through Wednesday, December 18, 2019 in Maui, Hawaii.

Slayback Pharma LLC announced the final approval and launch in the United States of Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection.

Model-based engineering toolsuite brings high reliability to medical device software

The company advances its sustainability initiatives by announcing first-ever five-year goals and committing to reporting its progress annually

Genetic Technologies Limited is pleased to announce the full commissioning of its Australian Laboratory for the provisioning of its generation 3 breast cancer test with sales to commence in Q1, 2020.

Shoulder Innovations,, a leading innovator in the development of shoulder replacement systems, announced that they have received FDA clearance for their InSet Plus™ augmented glenoids for the InSet™ Total Shoulder System.

MYOS RENS Technology, Inc. (“MYOS” or “the Company”) (NASDAQ: MYOS), announced today that it will launch its longevity business with the introduction of its Physician Muscle Health Formula® at the 27th World Congress on Anti-Aging Medicine (https://www.a4m.com/las-vegas-december-2019.html) in Las Vegas, Nevada from December 13-15, 2019; MYOS will be in Booth #2090.

Diverse Biotech, Inc. www.diversebiotech.com has announced it has successfully synthesized and progressed into pre-clinical testing its first two new chemical entities developed using its proprietary CuSP-C2 technology platform.